Barriers to generating PDX models of HPV-related head and neck cancer

被引:30
|
作者
Facompre, Nicole D. [1 ]
Sahu, Varun [1 ]
Montone, Kathleen T. [1 ,2 ]
Harmeyer, Kayla M. [1 ]
Nakagawa, Hiroshi [3 ]
Rustgi, Anil K. [3 ]
Weinstein, Gregory S. [1 ]
Gimotty, Phyllis A. [4 ]
Basu, Devraj [1 ,5 ,6 ]
机构
[1] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, 3400 Spruce St,5 Ravdin Silverstein, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA
[5] Philadelphia VA Med Ctr, Philadelphia, PA USA
[6] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA
来源
LARYNGOSCOPE | 2017年 / 127卷 / 12期
关键词
Patient-derived xenograft; HPV; head and neck cancer; preclinical model; SQUAMOUS-CELL CARCINOMA; PAPILLOMAVIRUS-POSITIVE HEAD; PATIENT-DERIVED XENOGRAFTS; HUMAN-MALIGNANT TUMOR; OROPHARYNGEAL CANCER; LUNG-CANCER; NUDE-MICE; IMMUNODEFICIENT MICE; EPITHELIAL-CELLS; ROCK INHIBITOR;
D O I
10.1002/lary.26679
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/HypothesisDelineate factors impacting the creation and use of patient-derived xenografts (PDXs) of human papilloma virus-related (HPV+) head and neck squamous cell carcinomas (HNSCCs). Study DesignLaboratory-based translational study. MethodsFifty-one surgically resected HNSCCs, including 31 HPV+cancers, were implanted into NOD/SCID/IL-2R(-/-) (NSG) mice using standardized methodology. Clinical and pathologic factors were tested for association with engraftment. The gross, histologic, and molecular features of established HPV+PDXs were analyzed in comparison to their tumors of origin. ResultsNegative HPV status and perineural invasion (PNI) were independent, additive factors associated with increased PDX formation. Epstein-Barr virus-positive (EBV+) human large B-cell lymphomas grew from 32% of HPV+HNSCC cases that failed to engraft. Successfully established HPV+PDXs retained basaloid histology and often developed cystic growth patterns typical of HPV+nodal metastases. They also maintained elevated p16(INK4A) levels and expression of E6/E7 viral oncogene transcripts. ConclusionReduced engraftment by HPV+tumors lacking PNI likely results in selection biases in HNSCC PDX models. Formation of EBV+lymphomas in NSG mice further reduces the generation of HPV+models and must be ruled out before long-term use of PDXs. Nevertheless, the retention of distinctive pathologic traits and viral oncogene expression by HPV+PDXs provides a viable in vivo platform for basic and translational studies as well as a resource for generating advanced in vitro models. Level of EvidenceNA. Laryngoscope, 127:2777-2783, 2017
引用
收藏
页码:2777 / 2783
页数:7
相关论文
共 50 条
  • [1] A Review of HPV-Related Head and Neck Cancer
    Kobayashi, Kazuhiro
    Hisamatsu, Kenji
    Suzui, Natsuko
    Hara, Akira
    Tomita, Hiroyuki
    Miyazaki, Tatsuhiko
    [J]. JOURNAL OF CLINICAL MEDICINE, 2018, 7 (09)
  • [2] HPV-related Head and Neck Cancer in Ireland
    Coughlan, D.
    O'Connor, T.
    Keogh, I.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2013, 182 : 516 - 517
  • [3] HPV-RELATED HEAD AND NECK CANCER.
    McMenamin, Erin
    Hornberger, Mary Catherine
    [J]. ONCOLOGY NURSING FORUM, 2012, 39 (03) : E170 - E170
  • [4] Neoadjuvant Immunotherapy Strategies in HPV-Related Head-and-Neck Cancer
    Saito, Shin
    Shibata, Hirofumi
    Adkins, Douglas
    Uppaluri, Ravindra
    [J]. CURRENT OTORHINOLARYNGOLOGY REPORTS, 2022, 10 (01) : 108 - 115
  • [5] The Psychosocial Care Needs of Patients with HPV-Related Head and Neck Cancer
    Gold, Dorothy
    [J]. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2012, 45 (04) : 879 - +
  • [6] Neoadjuvant Immunotherapy Strategies in HPV-Related Head-and-Neck Cancer
    Shin Saito
    Hirofumi Shibata
    Douglas Adkins
    Ravindra Uppaluri
    [J]. Current Otorhinolaryngology Reports, 2022, 10 : 108 - 115
  • [7] HPV-related genome rearrangements in head and neck cancer cell lines
    Mukhina, Vera
    Anderson, Alexa
    Gaykalova, Daria A.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [8] Need for Diverse Population for HPV-Related Head and Neck Cancer Studies
    Washington, Caretia
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2023, 169 (04)
  • [9] Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer
    Saba, Nabil F. F.
    Pamulapati, Saagar
    Patel, Bhamini
    Mody, Mayur
    Strojan, Primoz
    Takes, Robert
    Maekitie, Antti A. A.
    Cohen, Oded
    Pace-Asciak, Pia
    Vermorken, Jan B. B.
    Bradford, Carol
    Forastiere, Arlene
    Teng, Yong
    Wieland, Andreas
    Ferlito, Alfio
    [J]. CANCERS, 2023, 15 (07)
  • [10] The pathology of HPV-related head and neck cancer: Implications for the diagnostic pathologist
    Westra, William H.
    [J]. SEMINARS IN DIAGNOSTIC PATHOLOGY, 2015, 32 (01) : 42 - 53